Biocair is a global GDP logistics specialist with over 35 years of experience in pharmaceutical, biotechnology and life sciences sectors, operating South African offices in Johannesburg, Cape Town and Durban plus an extensive network of qualified agents throughout the African continent. Biocair provides comprehensive temperature-controlled logistics for clinical trials, pharmaceutical distribution, cell and gene therapies, vaccine distribution, and medical research samples. The company builds its unique client-centric approach by employing scientists in front-line logistics positions and assembling best-in-class experts in quality, cold chain and regulatory compliance. Biocair’s South Africa network was instrumental in COVID-19 vaccine distribution across the country’s nine provinces, transporting the first 80,000 doses of Johnson & Johnson vaccine in February 2021. Their services include validated and pre-conditioned packaging for all temperature ranges, proactive shipment monitoring with contingency plans for delays, import/export permit assistance, and advanced tracking technologies. Biocair partners with the South African Clinical Research Association (SACRA), participating in regional workshops sharing best practices for clinical research logistics including cold chain management, customs clearance and packaging. Their MyCair track and trace system provides real-time shipment visibility. Services cover laboratory collections, clinical trial supplies, investigational medicinal products, ancillary supplies, and finished pharmaceutical products requiring temperature-controlled transport.

Cold Chain Relevance: Clinical trial cold chain logistics; pharmaceutical temperature-controlled shipping; vaccine distribution; GDP-compliant transport